Skip to content

INTERLEUKIN GENETICS INC

CIK 0001037649

← back to feed
Revenue (TTM)
$2.48M
+74.4% YoY Q1 May 2017
Net Income (TTM)
−$8.1M
+6.1% YoY Q1 May 2017
EPS Diluted (TTM)
—
Q1 May 2017
Gross Margin
34.1%
Q1 May 2017
Operating Margin
-299.3%
Q1 May 2017
Net Margin
-326.4%
Q1 May 2017
Free Cash Flow (TTM)
−$4.17M
Q1 May 2017
Cash
$790.74K
Q1 May 2017
Total Debt
$3.13M
Q1 May 2017
Shares Outstanding
229.47M sh
Q1 May 2017

Revenue & Net Income

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings